Global Cardiovascular Ultrasound System Market Global Industry Analyses 2016-2020 an opportunity forecasted 2020-2030
Market Overview
Cardiovascular ultrasound system, also known as Echocardiography is a noninvasive ultrasound way of monitoring the circulation in the body's blood arteries. Cardiovascular ultrasound system means the medical diagnostic of cardiovascular diseases. The device gives doctors and surgeons with pictures of the heart and valves to aid in surgical operations and therapy. Color and black-and-white displays are available for cardiovascular ultrasound systems. A transthoracic echocardiography, a transesophageal echocardiogram, and a stress echocardiography are among the tests performed. In hospitals and clinics, cardiovascular ultrasonography systems are often employed.
Global Cardiovascular Ultrasound System Market: Key Players
Chison Medical Imaging Co., Ltd.
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
Esaote SpA
FUJIFILM Holdings Corporation
GE Healthcare
Hitachi Medical Corporation
Mindray Medical International Ltd.
Philips Healthcare
Samsung Electronics Co., Ltd.
Siemens Healthineers
Toshiba Medical Systems Corporation
Ultrasound Technologies
Unetixs Vascular
Growth Factor
Increasing CVDs Boosts the Growth of Cardiovascular Ultrasound System Market
Cardiovascular disease is still a major source of morbidity and mortality in industrialized nations, and it is also becoming a major cause of death in emerging countries. CVDs are the leading cause of mortality worldwide, with more people dying from them each year than from any other cause. As a result, the need for cardiovascular ultrasound systems for diagnostics has grown as the incidence of cardiovascular disorders has grown.
Segmentation
By Test Type
Transthoracic Echocardiogram
Trans esophageal Echocardiogram
Stress Echocardiogram
Other Echocardiograms
By Technology
2D Ultrasound
3D & 4D Ultrasound
Doppler Imaging
By Device Display
Color Display
Black & White (B/W) Display
By End-User
Hospital and Cardiology Centers
Home and Ambulatory Care Settings
Research Institutes
Medical Device and Pharmaceutical Companies
Other End Users
Global Cardiovascular Ultrasound System Market Dynamics
Global Cardiovascular Ultrasound System Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints
Recent News Related to Market
In August 2018, EPIQ CVx cardiovascular ultrasonography system was announced by Koninklijke Philips N.V. It is intended to increase diagnostic confidence and simplify physician workflow by giving them more time to connect with their patients and reducing the need for repeat scans. It has deliberately combined sophisticated image quality measurement and intelligence. The company's product portfolio had been enhanced as a result of this product introduction.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
COVID-19 pre and post business impact analysis
Detailed overview of the parent market
Changing market dynamics in the industry
In-depth market segmentation
What is the Global Cardiovascular Ultrasound System Market growth?
Which segment accounted for the largest Global Cardiovascular Ultrasound System Market share?
Who are the key players in the Global Cardiovascular Ultrasound System Market?
Historical, current, and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint
Note: Although care has been taken to maintain the highest levels of accuracy in Fatpos Global’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Cardiovascular ultrasound system, also known as Echocardiography is a noninvasive ultrasound way of monitoring the circulation in the body's blood arteries. Cardiovascular ultrasound system means the medical diagnostic of cardiovascular diseases. The device gives doctors and surgeons with pictures of the heart and valves to aid in surgical operations and therapy. Color and black-and-white displays are available for cardiovascular ultrasound systems. A transthoracic echocardiography, a transesophageal echocardiogram, and a stress echocardiography are among the tests performed. In hospitals and clinics, cardiovascular ultrasonography systems are often employed.
Global Cardiovascular Ultrasound System Market: Key Players
Chison Medical Imaging Co., Ltd.
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
Esaote SpA
FUJIFILM Holdings Corporation
GE Healthcare
Hitachi Medical Corporation
Mindray Medical International Ltd.
Philips Healthcare
Samsung Electronics Co., Ltd.
Siemens Healthineers
Toshiba Medical Systems Corporation
Ultrasound Technologies
Unetixs Vascular
Growth Factor
Increasing CVDs Boosts the Growth of Cardiovascular Ultrasound System Market
Cardiovascular disease is still a major source of morbidity and mortality in industrialized nations, and it is also becoming a major cause of death in emerging countries. CVDs are the leading cause of mortality worldwide, with more people dying from them each year than from any other cause. As a result, the need for cardiovascular ultrasound systems for diagnostics has grown as the incidence of cardiovascular disorders has grown.
Segmentation
By Test Type
Transthoracic Echocardiogram
Trans esophageal Echocardiogram
Stress Echocardiogram
Other Echocardiograms
By Technology
2D Ultrasound
3D & 4D Ultrasound
Doppler Imaging
By Device Display
Color Display
Black & White (B/W) Display
By End-User
Hospital and Cardiology Centers
Home and Ambulatory Care Settings
Research Institutes
Medical Device and Pharmaceutical Companies
Other End Users
Global Cardiovascular Ultrasound System Market Dynamics
Global Cardiovascular Ultrasound System Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints
Recent News Related to Market
In August 2018, EPIQ CVx cardiovascular ultrasonography system was announced by Koninklijke Philips N.V. It is intended to increase diagnostic confidence and simplify physician workflow by giving them more time to connect with their patients and reducing the need for repeat scans. It has deliberately combined sophisticated image quality measurement and intelligence. The company's product portfolio had been enhanced as a result of this product introduction.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
COVID-19 pre and post business impact analysis
Detailed overview of the parent market
Changing market dynamics in the industry
In-depth market segmentation
What is the Global Cardiovascular Ultrasound System Market growth?
Which segment accounted for the largest Global Cardiovascular Ultrasound System Market share?
Who are the key players in the Global Cardiovascular Ultrasound System Market?
Historical, current, and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint
Note: Although care has been taken to maintain the highest levels of accuracy in Fatpos Global’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
1. EXECUTIVE SUMMARY
2. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. RESEARCH METHODOLOGY
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. AVERAGE PRICING ANALYSIS
5. MACRO-ECONOMIC INDICATORS
6. MARKET DYNAMICS
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. CORRELATION & REGRESSION ANALYSIS
7.1. Correlation Matrix
7.2. Regression Matrix
8. RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE
9. RISK ANALYSIS
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET ANALYSIS
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET
11.1. Market Size & forecast, 2020A-2030F
11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET: MARKET SEGMENTATION
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.2. Europe: (Germany, UK, and Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.3. Asia-Pacific: (China, India, Japan, South Korea, Australia, New Zealand and Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By Test Type: Market Share (2020-2030F)
12.2.1. Transthoracic Echocardiogram, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.2. Transesophageal Echocardiogram, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.3. Stress Echocardiogram, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.4. Other Echocardiograms, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By Technology: Market Share (2020-2030F)
12.3.1. 2D Ultrasound, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.2. 3D & 4D Ultrasound, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.3. Doppler Imaging, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4. By Device Display: Market Share (2020-2030F)
12.4.1. Color Display, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.2. Black & White (B/W) Display, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5. By End-User: Market Share (2020-2030F)
12.5.1. Hospital and Cardiology Centers, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5.2. Home and Ambulatory Care Settings, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5.3. Research Institutes, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5.4. Medical Device and Pharmaceutical Companies, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5.5. Other End Users, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
13. COMPANY PROFILE
13.1. Chison Medical Imaging Co., Ltd
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. Esaote SpA
13.3. FUJIFILM Holdings Corporation
13.4. GE Healthcare
13.5. Hitachi Medical Corporation
13.6. Mindray Medical International Ltd.
13.7. Philips Healthcare
13.8. Samsung Electronics Co., Ltd.
13.9. Siemens Healthineers
13.10. Toshiba Medical Systems Corporation
13.11. Ultrasound Technologies
13.12. Unetixs Vascular
Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
2. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. RESEARCH METHODOLOGY
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. AVERAGE PRICING ANALYSIS
5. MACRO-ECONOMIC INDICATORS
6. MARKET DYNAMICS
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. CORRELATION & REGRESSION ANALYSIS
7.1. Correlation Matrix
7.2. Regression Matrix
8. RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE
9. RISK ANALYSIS
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET ANALYSIS
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET
11.1. Market Size & forecast, 2020A-2030F
11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET: MARKET SEGMENTATION
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.2. Europe: (Germany, UK, and Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.3. Asia-Pacific: (China, India, Japan, South Korea, Australia, New Zealand and Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By Test Type: Market Share (2020-2030F)
12.2.1. Transthoracic Echocardiogram, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.2. Transesophageal Echocardiogram, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.3. Stress Echocardiogram, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.4. Other Echocardiograms, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By Technology: Market Share (2020-2030F)
12.3.1. 2D Ultrasound, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.2. 3D & 4D Ultrasound, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.3. Doppler Imaging, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4. By Device Display: Market Share (2020-2030F)
12.4.1. Color Display, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.2. Black & White (B/W) Display, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5. By End-User: Market Share (2020-2030F)
12.5.1. Hospital and Cardiology Centers, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5.2. Home and Ambulatory Care Settings, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5.3. Research Institutes, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5.4. Medical Device and Pharmaceutical Companies, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5.5. Other End Users, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
13. COMPANY PROFILE
13.1. Chison Medical Imaging Co., Ltd
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. Esaote SpA
13.3. FUJIFILM Holdings Corporation
13.4. GE Healthcare
13.5. Hitachi Medical Corporation
13.6. Mindray Medical International Ltd.
13.7. Philips Healthcare
13.8. Samsung Electronics Co., Ltd.
13.9. Siemens Healthineers
13.10. Toshiba Medical Systems Corporation
13.11. Ultrasound Technologies
13.12. Unetixs Vascular
Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
